Clinical Trial Detail

NCT ID NCT02057939
Title Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Leuprolide

Age Groups: adult

No variant requirements are available.